Dengue virus (DENV) is responsible for the most prevalent arthropod-borne viral infection in humans. Events decisive for disease development occur in the skin after virus inoculation by the mosquito. Yet, the role of human dermis-resident immune cells in dengue infection and disease remains elusive. Here we investigated how dermal dendritic cells (dDCs) and macrophages (dMs) react to DENV and impact on immunopathology. We show that both CD1c þ and CD14 þ dDC subsets were infected, but viral load greatly increased in CD14 þ dDCs upon IL-4 stimulation, which correlated with upregulation of virus-binding lectins Dendritic Cell-Specific Intercellular adhesion molecule-3-Grabbing Nonintegrin (DC-SIGN/CD209) and mannose receptor (CD206). IL-4 also enhanced T-cell activation by dDCs, which was further increased upon dengue infection. dMs purified from digested dermis were initially poorly infected but actively replicated the virus and produced TNF-a upon lectin upregulation in response to IL-4. DC-SIGN þ cells are abundant in inflammatory skin with scabies infection or Th2-type dermatitis, suggesting that skin reactions to mosquito bites heighten the risk of infection and subsequent immunopathology. Our data identify dDCs and dMs as primary arbovirus target cells in humans and suggest that dDCs initiate a potent virus-directed T-cell response, whereas dMs fuel the inflammatory cascade characteristic of dengue fever.
INTRODUCTION
The skin is the portal to infectious pathogens, in particular those transmitted by biting insects. Dengue virus (DENV) is a positive-strand RNA virus that belongs to the Flavivirus genus of the flaviviridae family and is transmitted by Aedes mosquitoes. The virus is responsible for the most prevalent arthropodborne viral infection in humans, with an estimate of 390 million cases per year worldwide (Bhatt et al., 2013) . Infection with DENV results in a wide spectrum of clinical manifestations ranging from mild, undifferentiated fever to hemorrhage and hypovolemic shock, which can be fatal if untreated (Rigau-Perez et al., 1998) . The global health burden of dengue infections is likely to further increase through sustained travel and vector spread; yet, efficient drugs or vaccines are currently unavailable. It is widely believed that the immune response mounted against the virus greatly contributes to pathogenesis (Green and Rothman, 2006; Mongkolsapaya et al., 2003; Pang et al., 2007) ; yet, our incomplete comprehension of the etiology of DENV-mediated diseases represents a serious hurdle to clinical prognosis and therapeutic action. A level of complexity in the understanding of arbovirus infection is introduced by the insect vector itself. Mosquito salivary proteins trigger Th2 polarization (Cox et al., 2012; Espada-Murao and Morita, 2011; Thangamani et al., 2010) and cause allergic skin reaction (Peng and Simons, 2007) . Insect saliva enhances infection of a number of insectvectorized pathogens including Dengue virus (Cox et al., 2012; Styer et al., 2011) . Moreover, inflammatory skin manifestations are observed during an ongoing dengue infection (Saleem and Shaikh, 2008) .
DENV, like many other pathogens, enters cells through carbohydrate-binding receptors that normally enable DCs and macrophages (Ms) to sample antigens (Navarro-Sanchez et al., 2003; Tassaneetrithep et al., 2003; van Kooyk and Geijtenbeek, 2003) . Thus, monocyte-derived DCs and monocyte-derived Ms that carry the C-type lectins Dendritic Cell-Specific Intercellular adhesion molecule-3-Grabbing Nonintegrin (DC-SIGN/CD209) and Mannose Receptor (MR/ CD206) are productively infected by DENV (Miller et al., 2008; Navarro-Sanchez et al., 2003; Tassaneetrithep et al., 2003) . They then release inflammatory cytokines such as tumor necrosis factor-a (TNF-a), which is thought to initiate an inflammatory cascade leading to Dengue (hemorrhagic) fever (Chen et al., 2008; Chen and Wang, 2002; Kwan et al., 2005; Nightingale et al., 2008) . Evidence that DC-SIGN has an important role in immunopathology was provided by the study of gene promoter polymorphism, showing that higher DC-SIGN levels increase the risk of developing Dengue fever (Sakuntabhai et al., 2005) .
Although the skin is the portal to arboviruses, whether skin-resident immune cells mediate DENV entry and impact on immunopathology remains incompletely understood. The epithelium-resident DCs, known as Langerhans cells (LCs), were shown to be infected (Wu et al., 2000) ; yet, these cells lack DC-SIGN and MR. Because dermal DCs (dDCs) and dermal Ms (dMs) express these receptors and represent plausible targets of DENV (Angel et al., 2006; Harman et al., 2013; Ochoa et al., 2008; Zaba et al., 2007) , elucidation of their role in DENV infection and pathology will help open new ways to disease prediction, vaccines, and treatments.
RESULTS

Cutaneous reactions increase the risk of infection by accumulation of DC-SIGN þ cells
We first assessed the risk of skin infection by determining the presence of cells expressing the C-type lectin DC-SIGN, an important DENV cell receptor (Navarro-Sanchez et al., 2003; Tassaneetrithep et al., 2003) . We compared the frequency of DC-SIGN þ cells in normal skin and, because mosquito-bitten skin is difficult to obtain, in skin lesions that resemble reactions to mosquito bites. Hence, we studied the skin from bullous pemphigoid, hypereosinophilic syndrome, mastocytosis, and scabies. These inflammations share with mosquito bites a number of features such as basophil recruitment and eosinophilia (Ito et al., 2011) . DC-SIGN expression was determined in combination with the CD163 marker, which is stably expressed by dMs and CD14 þ dDCs in different inflammatory milieus (Fuentes-Duculan et al., 2010; Haniffa et al., 2009; Pettersen et al., 2011; Zaba et al., 2007) . Cross sections were labeled for CD163 and DC-SIGN (Figure 1a) , and the cells exhibiting different combinations of
were counted ( Figure 1b ). DC-SIGN was predominantly expressed by CD163 þ myeloid cells both in normal and in inflamed skin. Only in mastocytosis did we see a population that expressed solely DC-SIGN. The mean number of CD163 þ DC-SIGN þ cells doubled from 24 to 51 per 0.125 mm 2 in bullous pemphigoid and mastocytosis and tripled to 78 in the hypereosinophilic syndrome and scabies. Therefore, these findings show that normal skin is vulnerable to DENV infection because it comprises DENV cell targets, and inflammation arising as a cutaneous reaction to insect bites heightens the infectious risk through increased numbers of DC-SIGN þ dDCs or dMs.
dDC subsets are permissive to DENV infection
The human dermis contains CD14 þ Ms, CD1a/c þ , and CD141
Hi dDCs (Angel et al., 2006; Chu et al., 2012; Haniffa et al., 2009; Haniffa et al., 2012; Nestle et al., 1993) . The latter subset was not studied because they constitute a very rare population. In addition, the dermis includes another CD14
þ migratory subset, which we will refer to as CD14 þ dDCs according to their original classification, although recent investigations have demonstrated their proximity to monocytes rather than DCs (McGovern et al., 2014) . We isolated a suspension of immune cells from normal skin, comprising dDC subsets, as well as LCs and T cells, following their spontaneous migration from skin explants into culture medium (Nestle et al., 1993 ; Figure 2a ). In comparison with CD1c þ dDCs, the CD14 þ dDCs expressed lower levels of HLA-DR, more MR, and exclusively DC-SIGN, in accordance with previous findings (Harman et al., 2013; Ochoa et al., 2008; Figure 2b) . We assessed DENV infection by exposing unseparated DCs to insect cell-produced DENV (strain 16681, serotype 2) at a multiplicity of infection of 0.5. Viral load was measured after 2 days for each subset by intracellular DENV-E protein labeling and flow cytometry based on HLA-DR and CD14 expression (Figure 2c ). Both the HLA-DR hi CD14 À and the HLA-DR lo CD14 þ subsets were infected by the pathogen. We verified viral accumulation by confocal microscopy and observed DENV-E protein in HLA-DR lo CD14 þ DCs (Figure 2d ). There was a vesicle-like distribution of the protein with partial overlap with CD14 and HLA-DR markers, suggesting an association of the virus with the exocytic pathway. To better distinguish between infection of CD1c þ dDCs, CD14 þ dDCs, and LCs, we used a complementary gating strategy based on Langerin, DC-SIGN, and differences in HLA-DR expression ( Supplementary Fig. 1a) Supplementary Figure 1c) . Hence, dDCs are infectious targets for DENV.
IL-4 stimulates productive infection of CD14
þ dDCs
Arbovirus infectivity and pathogenicity have been correlated with Th2-type immune reactions provoked by mosquito salivary compounds (Cox et al., 2012; Styer et al., 2011) . Th2-type immunity is characterized by the release of IL-4 by basophils, mast cells, and T cells. We therefore investigated the impact of IL-4 on DC infection. To this end, we allowed DCs to migrate into a medium lacking or containing IL-4, harvested the cells, and exposed them to DENV. Two days later, viral titers were determined. As shown in Figure 3a , the viral titer was significantly elevated when DCs were conditioned by IL-4. To determine whether the increased viral production was the result of higher infection of one particular DC subset, we determined the intracellular of DENV-E protein content in each subset by flow cytometry. We found a greatly increased viral load in IL-4-stimulated CD14 þ dDCs but not in CD1c þ dDCs or LCs ( Figure 3b ; Supplementary Figure 1b and c). Visual inspection by confocal microscopy showed DENV-E protein evenly distributed throughout the cytoplasm of HLA-DR lo CD14 þ dDCs, whereas HLA-DR hi CD14 À DCs were devoid of intracellular E protein ( Figure 3c ). Because IL-4 stimulates DC-SIGN and MR synthesis (Relloso et al., 2002) , we determined expression of these lectins in both dDC subsets. Indeed, IL-4 triggered an upregulation of DC-SIGN and MR on CD14 þ dDCs but not on CD1c þ dDCs ( Figure 3d ). Therefore, the presence of IL-4 strongly enhances DENV infection of the CD14 þ dDC subset, reflecting its higher DC-SIGN and MR levels.
IL-4-activated dMs are infected by DENV
We next examined whether DENV infects dMs. As dMs are non-migratory, enzymatic digestion was necessary to isolate the cells from the tissue (Angel et al., 2006; Zaba et al., 2007) . After culturing the dermal cell suspension for 2 days, CD14
þ HLA-DR þ cells were purified by flow cytometric cell sorting (Supplementary Figure 2) . Electron microscopy showed that the purified cells displayed typical dM morphology with melanin-loaded vesicles and few cell membrane protrusions, in contrast to DCs (Figure 4a , left and right; Lenz et al., 1993) . Analysis of cell surface markers disclosed that dMs expressed high levels of CD14 and HLA-DR but surprisingly little DC-SIGN and MR (Figure 4b , condition without cytokines). As this may be attributable to enzymatic digestion or to cell dedifferentiation after isolation from the skin, we searched for conditions that would restore DC-SIGN and MR expression. In view of the stimulatory effect of IL-4 on CD14 þ DCs, we cultured the cell suspension for 2 days with IL-4. In addition, because we had previously found that also IL-10 induced DC-SIGN expression on monocytes, we cultured the cells in IL-10 ( Kwan et al., 2008) . DC-SIGN and MR levels clearly increased in response to IL-4; however, IL-10 had no effect (Figure 4b ). To further enhance lectin levels, we exposed dMs to IL-4 and GM-CSF, which resulted in a boost of DC-SIGN and MR levels (Figure 4b ). Concomitantly, HLA-DR expression increased, whereas CD14 levels dropped. The cells developed a DC-like morphology with more cytoplasmic extensions but fewer phagosomes reminiscent of DCs (Figure 4a ). We then assessed DENV infection of dMs obtained without cytokines, with IL-4 and with IL-4/GM-CSF by exposing the purified cells to DENV, followed after 2 days by intracellular DENV-E protein flow cytometric analysis. Untreated dMs were poorly infected, but IL-4-stimulated dMs became highly permissive to DENV, which was further enhanced by GM-CSF (Figure 4c ). Thus, dMs are infectious targets for DENV when they express the viral-attachment lectins DC-SIGN and MR.
DENV-infected dMs release TNF-a, and IL-4 enhances the immunostimulatory function of dDCs
To evaluate the impact of DENV infection of dDCs and dMs on dengue disease development, we determined their potential to stimulate the immune response. Given its cardinal role in dengue pathologies, we first determined the production of TNF-a. Except for one donor, there was very little TNF-a released by virus-infected dDCs. Moreover, IL-4 could not elevate its production (Figure 5a ). On the other hand, TNF-a was produced by dMs, in particular when activated with IL-4 or with IL-4/GM-CSF, reflecting increased viral load ( Figure 5b ). Next, we evaluated whether IL-4 affected the ability of dDCs and dMs to stimulate helper T cells. For this, we performed mixed lymphocyte reactions with allogeneic naive CD4 þ T cells. We found that IL-4 enhanced the T-cell stimulatory capacity of dDCs (Figure 5c ). To better assess the consequences of DENV infection for the T-cell immune response, we also measured naive T-cell proliferation induced by infected dDCs. We found that infection further stimulates T-cell activation ( Figure 5d ). As dMs are poor naive T-cell stimulators (Haniffa et al., 2009 ) and remain within the tissue, we cultured them together with total blood CD4 þ T cells that include memory T cells. Proliferation induced by untreated dMs was low, but IL-4 and IL-4/GM-CSF converted the cells into better T-cell stimulators (Figure 5e ). Taken together, these results predict that the major consequence of DENV infection of dDCs would be a potent virus-directed T-cell response, whereas DENV-infected dMs would principally fuel the local inflammatory reaction.
DISCUSSION
Although dDCs and dMs reside in the most arbovirus-exposed tissue and are equipped with pattern recognition receptors such as C-type lectins (Harman et al., 2013; Ochoa et al., 2008; Turville et al., 2002) , the question of their role in pathogen entry and disease progression has been little explored. We addressed this question using the dengue pathogen, because (i) the virus is inoculated into the skin by mosquitoes, (ii) it recognizes DC-SIGN and MR lectins, and (iii) the early infection events are likely to have a profound effect on progression to life-threatening disease. In this report, we have shown that CD1c þ and CD14 þ dDCs as well as dMs are primary cell targets for DENV and that IL-4 has an outstanding influence on their viral infection and the immune response. E Schaeffer et al.
Dengue virus infects human dermal immune cells
To determine whether DENV infects the two distinct dDC subsets, we adopted an unbiased approach by exposing dermal emigrants to DENV, followed by FACS analysis. Both CD1c þ and CD14 þ dDCs were infected by DENV and the latter often yielded a higher viral load, probably as a result of increased DC-SIGN and MR expression. The finding that LCs were poorly infected supports previous observations using in vitro generated LCs (Lozach et al., 2005) and further highlights the importance of the dermal antigen presenting cells in DENV infection. When stimulated with IL-4, CD14 þ dDCs infection reached levels as high as 90%, correlating with greatly upregulated DC-SIGN and MR levels. We could not detect a significant production of TNF-a by dDCs, irrespective of activation by IL-4, in line with other reports that failed to observe TNF-a production by either CD1c þ or CD14 þ dDCs in response to a wide range of stimuli (Haniffa et al., 2009; Haniffa et al., 2012) . Instead, the consequences of DENV infection of dDCs are most likely pathogen transport to draining lymph nodes and the priming of virus-specific T cells. This would lead to an anti-viral adaptive immune response, considered a key event in dengue pathologies (Rothman and Ennis, 1999) . In view of the findings that CD14 þ dDCs skew the immune response to humoral immunity (Klechevsky et al., 2008; Matthews et al., 2012) , a privileged infection of the CD14 þ subset would result in an enhanced antibodymediated immune response. It is believed that a humoral response heightens the risk of immunopathology during a secondary infection with a heterotypic DENV serotype (Halstead and O'Rourke, 1977) . It is therefore tempting to speculate the existence of a positive feedback loop between CD14 þ dDC infection and humoral immunity that becomes relevant with repetitive DENV infections and may provide an understanding into the increased risk of disease development with multiple viral exposures.
Because of an absence of DC-SIGN and MR expression by dMs after their purification from the skin and in keeping with the idea that skin inflammation is likely to affect the susceptibility of dermal immune cells to infection, we found a prominent effect of IL-4, reinforced by GM-CSF, on DC-SIGN and MR expression by dMs. This also demonstrates an unexpected plasticity of dMs. dMs and CD14 þ dDCs share a number of phenotypic markers, and recent findings have shown that CD14 þ dDCs should be considered as an intermediate phenotype between monocytes and Ms (McGovern et al., 2014) . Despite this distinction, the CD14 þ cells that we purified from digested dermis formed a homogeneous population with characteristic features of Ms. This suggests that CD14 þ dDCs might have differentiated into Ms during ex vivo culture, possibly under the influence of dermal fibroblasts (Chomarat et al., 2000) . This plasticity further extends recent views on the ontogenic proximity of CD14 þ dDCs and monocytes (McGovern et al., 2014) . IL-4-treated Ms and CD14 þ dDCs show characteristics shared with DCs generated from blood monocytes with GM-CSF and IL-4 in vitro--i.e., downregulation of CD14 and increased expression of DC-SIGN--although we did not observe upregulation of CD1a in the dermis or in a culture with IL-4 and GM-CSF. Furthermore, the greater susceptibility to DENV infection upon differentiation of CD14 þ dermal cells is also reminiscent of previous studies comparing monocytes exposed or not to IL-4 (Miller et al., 2008) .
As can be expected from the levels of the lectins, together with their active cytoplasm, reflecting intensive endocytosis and biosynthesis, IL-4-activated dMs were clearly permissive to DENV infection. Infected dMs produced high levels of TNF-a, which is thought to be the key cytokine for the development of dengue fever ( conditions. T-cell proliferation was measured as the loss of CFSE. The data are representative of three donors. Statistical significance was determined by unpaired Student's t-test. *Po0.05; **Po0.01; ***Po0.001; NS, nonsignificant.
priming compared with dDCs, even when activated by IL-4, we propose that the principal contribution of dMs in dengue disease lies in inflammation with systemic and local consequences: (i) systemic activation of the immune system promoting dengue fever and (ii) local inflammation resulting in recruitment of immune cells, including lectin-expressing dMs and dDCs, as well as memory T cells. Therefore, dMreleased TNF-a would fuel skin inflammation initiated by the response to insect-derived salivary compounds and thus would propel a loop that would render the skin highly vulnerable to infection. Although studies in animal models have revealed a major impact of mosquito saliva and their immune stimulatory action on infectivity and viral pathogenesis (Cox et al., 2012; Styer et al., 2011) , so far no correlation has been made in humans between hypersensitivity and pathogenesis of arbovirus. Our finding that skin dermatitis resembling reactions to mosquito bites leads to a massive increase in CD163 þ dDCs or dMs that maintain DC-SIGN expression, taken together with the demonstration that these cells are infectious targets, provides a first experimental basis for such a correlation in man.
By investigating how DENV is handled by resident dermal immune cells, we have uncovered a number of checkpoints that are likely to affect early on the pathogenesis of arboviruses in general and DENV in particular. The results also reveal that therapeutic or prophylactic action, such as interference with lectin binding and IL-4 producing reactions, would be efficacious at the skin level to prevent systemic spread of the virus and immunopathology.
MATERIALS AND METHODS
Purification of skin cells
Abdominal skin was obtained with written informed consent and institutional review board approval, in agreement with the Helsinki Declaration and French legislation. DCs were isolated by floating whole skin pieces for 3 days onto complete medium lacking or containing IL-4 (25 ng ml À 1 ; Nestle et al., 1993) . For dMs purification, the epidermis was removed after trypsin digestion (0.5% in phosphate-buffered saline) and the remaining dermis digested with collagenase and DNAse for 18 hours (Angel et al., 2006; Zaba et al., 2007) . The cell suspension was cultured in complete medium for 48 hours in the absence or presence of IL-4 (25 ng ml 
DENV production
The pDENV-2 replicon of DENV-2 16681 (5 mg; gift of Dr. E. Harris, University of California, Berkeley, CA) was linearized, phenolchloroform extracted, precipitated, and resuspended in RNase-free water. RNA was synthesized by in vitro transcription using the T7 RiboMax Large scale RNA production Systems (Promega, Madison, WI) with additional 7 mG(ppp)A RNA Cap Structure Analog (New England BioLabs, Ipswich, MA). The RNA was transfected into BHK-21 (10 6 cells per well) in a six-well plate using the Lipofectamine RNAiMax kit (Invitrogen): 50 ml RNA mixture in 200 ml Opti-MEM was added to 50 ml Lipofectamine in 200 ml Opti-MEM (Life-Technologies, Grand Island, NY), incubated for 20 minutes and added to 10 6 cells. After 3 hours, the supernatant was removed and cells were cultured in complete Glasgow MEM medium. Supernatants were collected, spun down to remove cells, and stored in aliquots at À 80 1C. DENV-2 was produced in C6/36 Aedes albopictus mosquito cells, maintained in Leibovitz L15 medium, by infection with viral supernatants of BHK-21 cells. C6/36 cell supernatants were collected and stored in aliquots at À 80 1C.
DENV infections
Skin-purified cells (0.5 Â 10 5 cells) were exposed to DENV serotype 2 (strain 16681) at a multiplicity of infection of 0.5. After incubation for 2 hours at 37 1C in serum-free medium, cells were washed and cultured in complete medium. After 2 days, cells were subjected to intracellular detection of the viral E protein.
Infection analysis
Cells were fixed with 4% (v/v) paraformaldehyde and permeabilized with 0.1% (v/v) Triton X-100 for 3 minutes at room temperature. After washing, they were labeled with mouse anti-DENV-E protein mAb (IgG1, 3H5-1, Millipore, Molsheim, France), followed by APC-antimouse IgG1 (BD Biosciences). We stained with anti-CD14 (AB383) followed by donkey anti-goat IgG-AlexaFluor488 (Molecular Probes, Invitrogen), anti-HLA-DR-PerCP (L243) and, where indicated, anti-DC-SIGN-AlexaFluor488 (111H2 IgG2b, Dendritics, Lyon, France). For analyses of LC infection among total crawlout cell suspensions, we combined anti-DC-SIGN-PerCP-Cy5.5 (DCN46), anti-Langerin/ CD207-PE (DCGM4, Dendritics), anti-HLA-DR-AlexaFluor700 (L203, R&D Systems, Minneapolis, MN), and Fixable Viability Dye-eBio780 (eBioscience, San Diego, CA). Fluorescence was measured by flow cytometry (FACSCalibur, BD Biosciences or Gallios, Beckman-Coulter), and the data analyzed using the Cell Quest Pro or FlowJo software. Titers in cell-free supernatants were determined by infection of Vero cells as previously described (Lambeth et al., 2005) .
Cytokine production
Two days after infection, cell supernatants were collected, and TNF-a was measured by ELISA (OptEIA, BD Biosciences).
T-cell stimulation assay
Graded doses of purified dMs or total skin crawlout cells were incubated with 5 Â 10 4 carboxyfluorescein succinimidyl ester (CFSE)-loaded total blood T cells or 10 5 naive CD4 þ T cells purified from peripheral blood by negative selection (Miltenyi Biotec), respectively, in 96-well round-bottom plates in complete medium. After 5-day incubation, the cells were labeled for CD3 and CD4 and analyzed by flow cytometry for CFSE dilution in the CD3 þ CD4 þ gate. Proliferation was determined as the proportion of T cells with decreased intensity of CFSE. Total skin crawlout cells were infected with DENV-2 for 2 days, and then graded doses were incubated with 10 5 CFSE-loaded naive CD4 þ T cells in 96-well plates in complete medium. After 5-day incubation, the cells were labeled with fixable viability dye-eBio780 and anti-CD3-AF700 (BD Biosciences). Live T cells (CD3 þ fixable viability dye-negative) were analyzed by flow cytometry for CFSE dilution.
Skin sections
Formol-fixed skin sections were cut and prepared for labeling with anti-CD163 mAb 10D6 and anti-DC-SIGN mAb 111H2 (Canard et al., 2011; Dendritics) . Counter staining was carried out with DAPI (4 0 ,6-diamidino-2-phenylindole). For diseased skins, two areas in the upper dermis and one in the reticular dermis were selected. Labeled cells were counted manually in three non-superimposable optical fields of 0.125 mm 2 using a computer-assisted image analysis Image J freeware.
Confocal and electron transmission microscopy
A total of 5 Â 10 4 cells per chamber were cultured on polylysine-coated slides (eight chamber Nunc Lab-Tek, Dutscher, Brumath, France) for 2 hours without serum, with or without DENV. Cells were collected and washed three times in complete medium before adding them back to the chamber. After 48 hours, the cells were fixed and labeled for DENV-E protein using Cy3-conjugated mAb 4G2 (kind gift from Dr. Philippe Despres, Institut Pasteur, Paris, France) together with PerCP-anti-HLA-DR (L243) and anti-CD14 (AB383, R&D Systems) followed by Alexa 488-donkey anti-goat (Molecular Probes, Invitrogen). DAPI was used as nuclear counterstaining. Slides were mounted using Fluromount (Dako, Les Ulis, France). Images were taken on Zeiss LSM 780 (Carl Zeiss, Jena, Germany) with GaAsP detector and Zen acquisition software (Zeiss). Images were further processed using the Image J freeware. Electron microscopy was performed as previously described (Kwan et al., 2008) .
